These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 16709449)

  • 21. Function of Cyp11a1 in animal models.
    Hu MC; Hsu HJ; Guo IC; Chung BC
    Mol Cell Endocrinol; 2004 Feb; 215(1-2):95-100. PubMed ID: 15026180
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vivo mouse imaging and spectroscopy in drug discovery.
    Beckmann N; Kneuer R; Gremlich HU; Karmouty-Quintana H; Blé FX; Müller M
    NMR Biomed; 2007 May; 20(3):154-85. PubMed ID: 17451175
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mouse models of Rett syndrome: from behavioural phenotyping to preclinical evaluation of new therapeutic approaches.
    Ricceri L; De Filippis B; Laviola G
    Behav Pharmacol; 2008 Sep; 19(5-6):501-17. PubMed ID: 18690105
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Investigating gene function using mouse models.
    Lee D; Threadgill DW
    Curr Opin Genet Dev; 2004 Jun; 14(3):246-52. PubMed ID: 15172666
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The influence of genetic background on spontaneous and genetically engineered mouse models of complex diseases.
    Linder CC
    Lab Anim (NY); 2001 May; 30(5):34-9. PubMed ID: 11385732
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Murine physiology: measuring the phenotype.
    Hoit BD
    J Mol Cell Cardiol; 2004 Aug; 37(2):377-87. PubMed ID: 15276007
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Using genetically engineered mouse models of cancer to aid drug development: an industry perspective.
    Singh M; Johnson L
    Clin Cancer Res; 2006 Sep; 12(18):5312-28. PubMed ID: 17000664
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo drug discovery in the zebrafish.
    Zon LI; Peterson RT
    Nat Rev Drug Discov; 2005 Jan; 4(1):35-44. PubMed ID: 15688071
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [A comprehensive form for the standardized characterization of transgenic rodents: genotype, phenotype, welfare assessment, recommendations for refinement].
    Mertens C; Rülicke T
    ALTEX; 2000; 17(1):15-21. PubMed ID: 11103109
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-throughput fluorescent screening of transgenic animals: phenotyping and haplotyping.
    Hellrung DJ; Rossi G; Link CJ
    Cytometry A; 2006 Oct; 69(10):1092-5. PubMed ID: 16998869
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetically modified animal models as tools for studying bone and mineral metabolism.
    Davey RA; MacLean HE; McManus JF; Findlay DM; Zajac JD
    J Bone Miner Res; 2004 Jun; 19(6):882-92. PubMed ID: 15125787
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetically engineered animals in drug discovery and development: a maturing resource for toxicologic research.
    Bolon B
    Basic Clin Pharmacol Toxicol; 2004 Oct; 95(4):154-61. PubMed ID: 15504150
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetically engineered mice: a new paradigm to study gastric physiology.
    Chen D; Zhao CM
    Curr Opin Gastroenterol; 2007 Nov; 23(6):602-6. PubMed ID: 17906435
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Animal models in biomedical research: transgenesis and gene targeting.
    Roes J
    Br J Hosp Med; 1997 Apr 16-May 6; 57(8):410-1. PubMed ID: 9274667
    [No Abstract]   [Full Text] [Related]  

  • 35. A novel transgenic mouse model produced from lentiviral germline integration for the study of beta-thalassemia gene therapy.
    Li W; Xie S; Guo X; Gong X; Wang S; Lin D; Zhang J; Ren Z; Huang S; Zeng F; Zeng Y
    Haematologica; 2008 Mar; 93(3):356-62. PubMed ID: 18268280
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phenotypic characterisation of mice with exaggerated and missing LH/hCG action.
    Ahtiainen P; Rulli S; Pakarainen T; Zhang FP; Poutanen M; Huhtaniemi I
    Mol Cell Endocrinol; 2007 Jan; 260-262():255-63. PubMed ID: 17029767
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Utilization of genetically altered animals in the pharmaceutical industry.
    Rudmann DG; Durham SK
    Toxicol Pathol; 1999; 27(1):111-4. PubMed ID: 10367684
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Unexpected and unexplained phenotypes in transgenic models.
    Murphy LJ; Silha JV
    Growth Horm IGF Res; 2000 Oct; 10(5):233-5. PubMed ID: 11042018
    [No Abstract]   [Full Text] [Related]  

  • 39. Mouse models of sickle cell disease.
    Beuzard Y
    Transfus Clin Biol; 2008; 15(1-2):7-11. PubMed ID: 18502677
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The roles of Wnt genes during mouse development].
    Takada S
    Tanpakushitsu Kakusan Koso; 1995 Oct; 40(14):2162-74. PubMed ID: 8532872
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.